Analysis of systemic risk factors in young patients with retinal vein occlusion
https://doi.org/10.21516/2072-0076-2025-18-1-24-29
Abstract
Purpose: to analyze systemic risk factors of retinal vein occlusion (RVO) in young patients. Material and methods. 23 patients with RVO aged 24–44 were enrolled in a prospective case series study. All patients underwent standard ophthalmological examination, blood pressure measurement, body mass index calculation, fasting glucose and total cholesterol test. Results. Most patients (73.91%) were diagnosed with central RVO, others (26.09%) had branch RVO. Modifiable cardiovascular risk factors were identified in 73.91% of patients. The most prevalent risk factors were overweight/obesity (60.27%) and hyperlipidemia (47.37%). Arterial hypertension, smoking and a combination of hyperlipidemia and overweight/obesity were identified in 34.78% of patients. High fasting glucose level was detected in 9.5% of patients. In four cases out of six without traditional risk factors, RVO was associated with COVID-19. One patient suffered from hereditary thrombophilia (Leiden’s mutation). Conclusion. RVO in young patients is associated with modifiable cardiovascular risk factors in 73.91% of cases. The impact of these risk factors and their combinations leads to vessels wall damage, local circulatory disturbance and hyperviscosity syndrome comprising a Virchow’s triad that underlies the pathogenesis of RVO.
About the Authors
A. B. Galimova
Bashkir State Medical University (Russian Centre for Eye and Plastic Surgery)
Russian Federation
Russian Federation
Aysylu B. Galimova — Cand. of Med. Sci., head of ophthalmological department # 2.
67, k1, Richard Sorge St., Ufa, Bashkortostan, 450075
V. U. Galimova
Bashkir State Medical University (Russian Centre for Eye and Plastic Surgery)
Russian Federation
Russian Federation
Venera U. Galimova — Dr. of Med. Sci., professor, professor of chair of ophthalmology.
67, k1, Richard Sorge St., Ufa, Bashkortostan, 450075
References
1. Rogers S, McIntosh RL, Cheung N, et al. The prevalence of retinal vein occlusion: pooled data from the United States, Europe, Asia and Australia. Ophthalmology. 2010; 117: 313–9. doi: 10.1016/j.ophtha.2009.07.017
2. Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2000; 98: 133–41; discussion 141–3. PMID: 11190017.
3. Tul’tseva S.N., Astakhov Yu.S. Retinal vein occlusions (etiology, pathogenesis, clinical presentation, diagnosis and treatment). Publisher: N-L — Saint-Petersburg, 2010 (In Russ.).
4. Gaba WH, Ahmed D, Al Nuaimi RK, et al. Bilateral central retinal vein occlusion in a 40-year-old man with severe coronavirus disease 2019 (COVID-19) pneumonia. Am J Case Rep. 2020; 21: e927691. doi: 10.12659/AJCR.927691
5. Walinjkar JA, Makhija SC, Sharma HR, et al. Central retinal vein occlusion with COVID-19 infection as the presumptive etiology. Indian J Ophthalmol. 2020; 68 (11): 2572–4. doi: 10.4103/ijo.IJO_2575_20
6. Ashkenazy N, Patel NA, Sridhar J, et al. Hemi- and central retinal vein occlusion associated with COVID-19 infection in young patients without known risk factors. Ophthalmology Retina. 2022; 6 (6): 520–30. https://doi.org/10.1016/j.oret.2022.02.004
7. Coscas G, Loewenstein A, Augustin A, Bandello F, et al. Management of retinal vein occlusion – Consensus document. Ophthalmologica. 2011; 226: 4–28. doi: 10.1159/000327391
8. Frangieh GT, Green WR, Barraquer-Somers E, Finkelstein D. Histopathologic study of nine branch retinal vein occlusions. Arch of Ophthalmol. 1982 Jul; 100 (7): 1132–40. doi: 10.1001/archopht.1982.01030040110020
9. Haymore JG, Mejico LJ. Retinal vascular occlusion syndromes. Int Ophthalmol Clin. 2009; 49: 63-79. doi: 10.1097/IIO.0b013e3181a8db88.
10. Kolar P. Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data. Journal of Ophthalmology. 2014. article ID 724780. http://dx.doi.org/10.1155/2014/724780
11. Erfurth-Schmidt U, Garcia-Arumi J, Gerendas BS, et al. Guidelines for the management of retinal vein occlusion by the European Society of retina specialists (EURETINA). Ophthalmologica. 2019; 242 (3): 123–62. doi: 10.1159/000502041
12. Cheung N, Klein R, Wang JJ, et al. Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis. Invest Ophthalmol Vis Sci. 2008 Oct; 49 (10): 4297–302. doi: 10.1167/iovs.08-1826
13. Astakhov Yu.S., Titarenko A.I., Tultseva S.N., et al. Systemic risk factors for retinal vein occlusion in young and middle-aged patients. Arterial hypertension. 2018; 24 (6): 666–73 (In Russ.). https://doi.org/10.18705/1607-419X-2018-24-6-666-673
14. Wittstr m E. Central retinal vein occlusion in younger Swedish adults: Case reports and review of the literature. Open Ophthalmol J. 2017; 11: 89–102. doi: 10.2174/1874364101711010089
15. Rothman AL, Thomas AS, Khan K, Fekrat S. Central retinal vein occlusion in young individuals: a comparison of risk factors and clinical outcomes. Retina. 2019; 39 (10): 1917–24. doi: 10.1097/IAE.0000000000002278
16. Chen TY, Uppuluri A, Zarbin MA, Bhagat N. Risk factors for central retinal vein occlusion in young adults. Eur J Ophthalmol. 2021; 31 (5): 2546–55. doi: 10.1177/1120672120960333
17. Zhang XT, Zhong YF, Xue YQ, Li SQ, et al. Clinical features of central retinal vein occlusion in young patients. Ophthalmol Ther. 2022; 11: 1409–22. https://doi.org/10.1007/s40123-022-00534-7
18. Hayreh SS, Podhajsky PA, Zimmerman MB. Natural history of visual outcome in central retinal vein occlusion. Ophthalmology. 2011; 118: 119–33. doi: 10.1016/j.ophtha.2010.04.019
19. Andreenko E.Yu., Yavelov I.S., Loukianov М.М., et al. Ischemic heart disease in subjects of young age: Current state of the problem: Prevalence and cardiovascular risk factors. Kardiologiia. 2018; 58 (10): 53–8 (In Russ.). doi: 10.18087/cardio.2018.10.10184
20. Fong AC, Schatz H. Central retinal vein occlusion in young adults. Surv Ophthalmol. 1993 May-Jun; 37 (6): 393–417. doi: 10.1016/0039-6257(93)90138-w. Erratum in: Surv Ophthalmol. 1993 Jul-Aug; 38 (1): 88. PMID: 8516752.
21. Dodson PM, Kritzinger EE. Underlying medical conditions in young patients and ethnic differences in retinal vein occlusion. Trans Ophthalmol Soc UK (1962). 1985; 104 (Pt 2): 114–9. PMID: 3857768.
22. Kuo JZ, Lai CC, Ong FS, et al. Central retinal vein occlusion in a young Chinese population: risk factors and associated morbidity and mortality. Retina. 2010; 30 (3): 479–84. doi: 10.1097/IAE.0b013e3181b9b3a0
23. Dodson PM, Westwick J, Marks G, Kakkar VV, Galton DJ. beta-thromboglobulin and platelet factor 4 levels in retinal vein occlusion. Br J Ophthalmol. 1983; 67 (3): 143–6. doi: 10.1136/bjo.67.3.143
24. Di Capua M, Coppola A, Albisinni R, Tufano A, et al. Cardiovascular risk factors and outcome in patients with retinal vein occlusion. J Thromb Thrombolysis. 2010; 30: 16–22. doi: 10.1007/s11239-009-0388-1
25. O'Mahoney PR, Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol. 2008; 126: 692–9. doi: 10.1001/archopht.126.5.692
26. Kida T, Flammer J, Oku H, Konieczka K, et al. Vasoactivity of retinal veins: a potential involvement of endothelin-1 (ET-1) in the pathogenesis of retinal vein occlusion (RVO). Exp Eye Res. 2018; 176: 207–9. https://doi.org/10.1016/j.exer.2018.07.016
27. Hayreh SS, Zimmerman MB, McCarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol. 2001 Jan; 131 (1): 61–77. doi: 10.1016/s0002-9394(00)00709-1
28. Yavnaya I.K. Smoking influence on cardiovascular system: microcirculatory tract and endothelium. Dal’nevostochnyi meditsinskiy zhurnal. 2012; 2: 136–9 (In Russ.).
29. Chang YS, Ho CH, Chu CC, et al. Risk of retinal vein occlusion in patients with diabetes mellitus: A retrospective cohort study. Diabetes Res Clin Pract. 2021; 171: 108607. https://doi.org/10.1016/j.diabres.2020.108607
30. Terasaki H, Ogura Y, Kitano S, et al. Management of diabetic macular edema in Japan: a review and expert opinion. Jpn J Ophthalmol. 2018; 62 (1): 1–23. doi: 10.1007/s10384-017-0537-6
31. Khokhlova D.Yu., Drozdova E.A. Analysis of systemic risk factors in patients with retinal vein occlusion. Meditsinskiy vestnik Bashkortostana. 2014; 9 (2): 144–7 (In Russ.).
32. Khan SS, Ning H, Wilkins JT, et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol. 2018; 3 (4): 280–7. doi: 10.1001/jamacardio.2018.0022
33. Paik DW, Han K, Kang SW, et al. Differential effect of obesity on the incidence of retinal vein occlusion with and without diabetes: a Korean nationwide cohort study. Sci Rep. 2020; 10 (1): 10512. doi: 10.1038/s41598-020-67375-x
34. Galimova A.B. Clinical case of combined central retinal artery and central retinal vein occlusion in COVID-19. Meditsinskiy vestnik Bashkortostana. 2021; 16 (4): 36–9 (In Russ.).
35. Sheth JU, Narayanan R, Goyal J, Goyal V. Retinal vein occlusion in COVID-19: a novel entity. Indian J Ophthalmol. 2020; 68 (10): 2291–3. doi: 10.4103/ijo.IJO_2380_20
Review
For citations:
Galimova A.B., Galimova V.U. Analysis of systemic risk factors in young patients with retinal vein occlusion. Russian Ophthalmological Journal. 2025;18(1):24-29. (In Russ.) https://doi.org/10.21516/2072-0076-2025-18-1-24-29
Views:
119
Email this article 